Second line biological therapy in paediatric IBD: Effective but carries significant financial and safety implications.

D. Wilson, M. Wilson, R. Russell, Adalimumab Study Grp B

Research output: Contribution to journalBook/Film/Article reviewpeer-review

Original languageEnglish
Pages (from-to)S39-S39
Number of pages1
JournalInflammatory Bowel Diseases
Volume17
Publication statusPublished - Jan 2011

Cite this